Merck Sharpe & Dohme Formulation Plant, Tuas, Singapore
Key Data:
Order year
Late 2001
Project type
Formulation facility
Location
Tuas, Singapore
Estimated investment
$100 million
Completion
October 2003
Output chemicals
Combination cholesterol therapy. Zocor and Ezetrol (Zetia)
Key Players:
Sponsor
MSD Technology Singapore Pte Ltd
Lead engineer / designer
Foster Wheeler
Validation
Foster Wheeler
Contractor
Hycon
Financing
Merck Sharpe & Dohme
